Accéder au contenu principal

Ebba obtained a Master degree in Neurochemistry in 1998 (Stockholm University, Sweden), followed by a PhD degree in 2003 at the Karolinska Institutet, Sweden on the topic of angiogenesis in tumor growth and obesity, under the supervision of Prof. Yihai Cao. She completed her postdocoral training with Prof Lily Wu at UCLA, USA, analysing the role of lymphangiogenesis in prostate cancer metastasis. In 2006, she obtained a tenured research position at Inserm to work in the Cardiovascular Research laboratory Inserm U644 /U1096 directed by Prof. C Thuillez in Rouen, France. Since 2019, she has apposition as Director of Research at Inserm and vice-director of the Inserm U1096 laboratory in Rouen.Ebba is an Expert on vascular cell biology, and she has developed innovative experimental biotherapies to stimulate blood and lymphatic vascular regrowth in injured hearts with the aim to prevent heart failure. Ebba has been PI or co-PI on several recent national or European grants, including the ERA-CVD LYMIT-DIS (2017-2021), ANR RESIST-HF (2018-2022), and DFG/ANR CITE-LYMPH (2023-2026) focused on mechanisms and treatments for acute or chronic heart failure. Her current work is centred on unravelling the impact of inflammation on cardiac function, including investigating the cross-talk between immune cells and cardiac lymphatics.

https://orcid.org/0000-0003-3378-8300